About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gt(ROSA)26Sortm3(tetO-Mir193)Arte
targeted mutation 3, TaconicArtemis
MGI:5512655
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gt(ROSA)26Sortm3(tetO-Mir193)Arte/Gt(ROSA)26Sortm3(tetO-Mir193)Arte involves: 129 * BALB/c * C57BL/6 MGI:5512667
ht2
Gt(ROSA)26Sortm3(tetO-Mir193)Arte/Gt(ROSA)26Sor+ involves: 129 * BALB/c * C57BL/6 MGI:5512665


Genotype
MGI:5512667
hm1
Allelic
Composition
Gt(ROSA)26Sortm3(tetO-Mir193)Arte/Gt(ROSA)26Sortm3(tetO-Mir193)Arte
Genetic
Background
involves: 129 * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(tetO-Mir193)Arte mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• after 6 weeks in doxycycline-treated mice

renal/urinary system
• in doxycycline-treated mice
• contracted kidneys with tubular atrophy, scarring, cyst formation and focal tubular regeneration in dead doxycycline-treated mice
• in dead doxycycline-treated mice
• from 4 weeks on in doxycycline-treated mice
• fused from 4 weeks on in doxycycline-treated mice
• doxycycline-treated mice exhibit progressive glomerular lesions and irregularities that progress to focal sclerosis unlike in control mice
• focal sclerosis in doxycycline-treated mice that is elevated with time
• focal tubular regeneration in dead doxycycline-treated mice
• in dead doxycycline-treated mice

homeostasis/metabolism
• in doxycycline-treated mice

growth/size/body
• in dead doxycycline-treated mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
focal segmental glomerulosclerosis DOID:1312 OMIM:PS603278
J:197989




Genotype
MGI:5512665
ht2
Allelic
Composition
Gt(ROSA)26Sortm3(tetO-Mir193)Arte/Gt(ROSA)26Sor+
Genetic
Background
involves: 129 * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(tetO-Mir193)Arte mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• after 12 weeks in doxycycline-treated mice

renal/urinary system
• in doxycycline-treated mice
• contracted kidneys with tubular atrophy, scarring, cyst formation and focal tubular regeneration in dead doxycycline-treated mice
• in dead doxycycline-treated mice
• from 4 weeks on in doxycycline-treated mice
• fused from 4 weeks on in doxycycline-treated mice
• doxycycline-treated mice exhibit progressive glomerular lesions and irregularities that progress to focal sclerosis unlike in control mice
• focal sclerosis in doxycycline-treated mice that is elevated with time
• focal tubular regeneration in dead doxycycline-treated mice
• in dead doxycycline-treated mice

homeostasis/metabolism
• in doxycycline-treated mice

growth/size/body
• in dead doxycycline-treated mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
focal segmental glomerulosclerosis DOID:1312 OMIM:PS603278
J:197989





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory